BioHiTech Global Reports First Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
UPDATE: BioHiTech Global, Inc. (BHTG) Reports Q1 Loss of $0.49
May 16, 2018 8:33 AM EDT(Updated - May 16, 2018 8:34 AM EDT)
BioHiTech Global, Inc. (NASDAQ: BHTG) reported Q1 EPS of ($0.49). Revenue for the quarter came in at $646 thousand.
Q1 Financial Highlights
Revenue: Revenues in Q1 2018 were $646,000, a 9.3% increase compared to revenues of $591,000 in Q1 2017. Recurring revenue from rental, services and maintenance grew by 22.9% to reach $440,000 or 68.2% of total revenue. The increase in rental, service and maintenance is primarily the result of a larger overall number of deployed units that led to a 42.1% increase in pure rental revenues. Recurring revenue from management advisory fees related to its new management... More